Amedisys EBITDA Margin 2010-2024 | AMED
Current and historical EBITDA (Earnings Before Interest, Taxes, Depreciation and Amortization) margin for Amedisys (AMED) over the last 10 years. The current EBITDA margin for Amedisys as of September 30, 2024 is .
| Amedisys EBITDA Margin Historical Data |
| Date |
TTM Revenue |
TTM EBITDA |
EBITDA Margin |
| 2024-09-30 |
$2.32B |
$0.21B |
9.00% |
| 2024-06-30 |
$2.29B |
$0.22B |
9.61% |
| 2024-03-31 |
$2.25B |
$0.21B |
9.15% |
| 2023-12-31 |
$2.24B |
$0.22B |
9.66% |
| 2023-09-30 |
$2.23B |
$0.23B |
10.33% |
| 2023-06-30 |
$2.23B |
$0.23B |
10.32% |
| 2023-03-31 |
$2.23B |
$0.24B |
10.88% |
| 2022-12-31 |
$2.22B |
$0.25B |
11.34% |
| 2022-09-30 |
$2.22B |
$0.26B |
11.58% |
| 2022-06-30 |
$2.22B |
$0.28B |
12.42% |
| 2022-03-31 |
$2.23B |
$0.30B |
13.66% |
| 2021-12-31 |
$2.23B |
$0.32B |
14.55% |
| 2021-09-30 |
$2.23B |
$0.34B |
15.15% |
| 2021-06-30 |
$2.22B |
$0.34B |
15.49% |
| 2021-03-31 |
$2.16B |
$0.32B |
14.58% |
| 2020-12-31 |
$2.11B |
$0.29B |
13.63% |
| 2020-09-30 |
$2.05B |
$0.26B |
12.83% |
| 2020-06-30 |
$2.00B |
$0.24B |
12.12% |
| 2020-03-31 |
$1.98B |
$0.24B |
11.86% |
| 2019-12-31 |
$1.96B |
$0.23B |
11.91% |
| 2019-09-30 |
$1.89B |
$0.22B |
11.43% |
| 2019-06-30 |
$1.81B |
$0.20B |
10.93% |
| 2019-03-31 |
$1.73B |
$0.19B |
10.69% |
| 2018-12-31 |
$1.66B |
$0.17B |
10.17% |
| 2018-09-30 |
$1.63B |
$0.16B |
10.02% |
| 2018-06-30 |
$1.58B |
$0.15B |
9.35% |
| 2018-03-31 |
$1.55B |
$0.11B |
6.92% |
| 2017-12-31 |
$1.51B |
$0.10B |
6.42% |
| 2017-09-30 |
$1.46B |
$0.08B |
5.61% |
| 2017-06-30 |
$1.45B |
$0.07B |
5.10% |
| 2017-03-31 |
$1.44B |
$0.09B |
6.48% |
| 2016-12-31 |
$1.42B |
$0.08B |
5.56% |
| 2016-09-30 |
$1.41B |
$0.08B |
5.74% |
| 2016-06-30 |
$1.37B |
$0.08B |
6.04% |
| 2016-03-31 |
$1.33B |
$0.00B |
0.30% |
| 2015-12-31 |
$1.28B |
$0.01B |
0.94% |
| 2015-09-30 |
$1.24B |
$0.01B |
0.97% |
| 2015-06-30 |
$1.22B |
$0.01B |
0.90% |
| 2015-03-31 |
$1.21B |
$0.09B |
7.12% |
| 2014-12-31 |
$1.21B |
$0.05B |
4.40% |
| 2014-09-30 |
$1.21B |
$0.03B |
2.49% |
| 2014-06-30 |
$1.21B |
$-0.14B |
-11.42% |
| 2014-03-31 |
$1.22B |
$-0.14B |
-11.65% |
| 2013-12-31 |
$1.25B |
$-0.12B |
-9.37% |
| 2013-09-30 |
$1.29B |
$-0.10B |
-7.37% |
| 2013-06-30 |
$1.35B |
$0.08B |
5.77% |
| 2013-03-31 |
$1.40B |
$0.09B |
6.29% |
| 2012-12-31 |
$1.44B |
$0.10B |
6.59% |
| 2012-09-30 |
$1.42B |
$0.11B |
7.55% |
| 2012-06-30 |
$1.42B |
$0.11B |
7.72% |
| 2012-03-31 |
$1.43B |
$0.13B |
9.38% |
| 2011-12-31 |
$1.42B |
$0.15B |
10.66% |
| 2011-09-30 |
$1.46B |
$0.19B |
12.69% |
| 2011-06-30 |
$1.49B |
$0.20B |
13.53% |
| 2011-03-31 |
$1.55B |
$0.22B |
14.03% |
| 2010-12-31 |
$1.60B |
$0.25B |
15.43% |
| 2010-09-30 |
$1.62B |
$0.26B |
16.09% |
| 2010-06-30 |
$1.60B |
$0.28B |
17.70% |
| 2010-03-31 |
$1.56B |
$0.29B |
18.33% |
| 2009-12-31 |
$1.48B |
$0.27B |
18.13% |
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
Medical - Outpatient & Home Care |
$2.744B |
$2.236B |
|
Amedisys Inc. provides home health and hospice services throughout the U.S. to the growing chronic, co-morbid, and aging American population. The company also offers clinically focused programs for chronic conditions and various diseases such as diabetes, coronary artery disease, congestive heart failure, orthopedics, complex wound care, geriatric surgical recovery, balance retraining, behavioral health and stroke recovery, as well as various rehabilitative programs. It provides hospice services to patients using an interdisciplinary care team comprising a physician, nurses, home health aides, social workers, therapists, dieticians, volunteers, counselors, chaplains and bereavement coordinators, when required. The company depends on reimbursement from Medicare (for chronic care) for a significant portion of its revenues on account of the age demographics of its patient base (average age of 81).
|
